BioVentureVoiCes

58 posts

BioVentureVoiCes

BioVentureVoiCes

@BioVentureVoiCe

Katılım Eylül 2024
2 Takip Edilen195 Takipçiler
Sabitlenmiş Tweet
BioVentureVoiCes
BioVentureVoiCes@BioVentureVoiCe·
BioVenture VoiCes is a new video podcast on @BiotechTVHQ that will feature leading VC investors to discuss heathcare venture investing from an insider's perspective to dig deeper into best practices, strategies, and emerging trends and shifting landscape of healthcare technology!
BiotechTV@BiotechTV

New Program Announcement: BioVenture VoiCes with Chris Garabedian. Today we welcome a regular new program on BiotechTV. @cngarabedian will host the top venture investors in biotech to get their insights on the sector. Watch here in the future: biotechtv.com/bioventure-voi…

English
0
1
3
1.2K
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Our next guest (Ep.37) on @BioVentureVoiCe video podcast will be Simeon George of SR One (srone.com), formerly known as GSK's CVC arm, where he has been leading investments for almost 20 years and orchestrated its spinout as an independent investment firm in 2020 as Founder and CEO. Simeon shares the firm's investment strategy since the spinout and what learnings he brought from his experiences at the legacy firm. Tune in early next week to listen to this episode of BioVenture VoiCes on @BiotechTV!
Chris Garabedian tweet media
English
0
1
8
831
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Our next guest (Ep.36) on @BioVentureVoiCe video podcast will be Jim Healy of Sofinnova Investments (sofinnova.com), where he has been leading biotech investments for over 25 years and joined the firm soon after completing his MD/PhD at Stanford. Sofinnova has embraced clinical-stage private investments across varied therapeutic categories long before this became a prevailing trend among many VCs in recent years. Tune in early next week to listen to this episode of BioVenture VoiCes on @BiotechTV!
Chris Garabedian tweet media
English
0
1
7
684
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Our next guest (Ep.35) on @BioVentureVoiCe video podcast will be Jessica Owens of INITIATE Ventures (initate.vc), a venture studio and early-stage VC she co-founded after her experience as a VC and serial entrepreneur at Kleiner Perkins, Versant and as co-founder and architect of Grail as a spinout of Illumina. Tune in early next week to listen to this episode of BioVenture VoiCes on @BiotechTV!
Chris Garabedian tweet media
English
1
1
6
545
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Our next guest (Ep.34) on @BioVentureVoiCe video podcast will be Brett Zbar of @generalatlantic, one of the larger PE firms, where he leads their life science investment practice. He joined General Atlantic after roles at McKinsey, Aisling and Foresite after his early experience as a Harvard MD and treating physician at Hopkins. Tune in early next week to listen to this episode of BioVenture VoiCes on @BiotechTV!
Chris Garabedian tweet media
English
0
1
19
985
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Listen to Episode 33 of @BioVentureVoiCe video podcast w/ Art Pappas of @pappas_capital and hear how 30 years of VC investing since the founding of the firm was born out of his pharma career building international operations and his relationships with industry partners in building out a broader investing platform with Pappas Capital. The full video is here on @BiotechTV (and also on Spotify and Apple Podcasts): biotechtv.com/post/bioventur…
BiotechTV@BiotechTV

𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: @pappas_capital's Art Pappas describes how his international experiences working for large companies led to the creation of Pappas Capital, and he walks us through the firm's investment strategy. Full video: biotechtv.com/post/bioventur…

English
0
2
16
1.6K
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Our next guest (Ep.33) on @BioVentureVoiCe video podcast will be Art Pappas of @pappas_capital, where he has been leading VC investments in life sciences for over 30 years. He shares how his 20+ career working in pharma leading international operations led to the founding of the firm and collaborative relationships that are still a pillar of the firm today. Tune in early next week to listen to this episode of BioVenture VoiCes on @BiotechTV !
Chris Garabedian tweet media
English
0
2
7
961
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
🔥Early release for #JPM26 🔥: Listen to Episode 32 of @BioVentureVoiCe video podcast w/ Bob Nelsen (@rtnarch) and hear about how Arch leans into risk-taking on great science in developing first-in-class technologies and platforms over their 40 year history. In the last 5 years (the most challeging market in biotech history), Arch has raised more money ($8B) and deployed more capital than any biotech VC and the firm doesn't have 'risk-averse' in their vocabulary. The full video is here on @BiotechTV (and also on Spotify and Apple Podcasts): biotechtv.com/post/bioventur…
BiotechTV@BiotechTV

𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: ARCH Venture Partners' @rtnarch on leadership, risk taking, the transformational promise of AI, and much more. Full video: biotechtv.com/post/bioventur…

English
3
9
41
6K
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Our next guest (Ep.32) on @BioVentureVoiCe video podcast will be Bob Nelson (@rtnarch) of Arch Venture Partners. Bob describes his early influences and the founding of Arch 40 years ago and how the firm has been risk-tolerant and being first on new technology areas from its inception. The firm continues to take big bets on new technology areas and platforms with ~$8B in new funds raised since 2021 (more than the company raised in its first 35 years). ⚡️We're releasing this episode on the Sunday before JPM⚡️ so you can listen in before the frenzy of the week begins - tune in to listen to this episode of BioVenture VoiCes on @BiotechTV!
Chris Garabedian tweet media
English
1
6
56
23.2K
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Listen to Episode 31 of @BioVentureVoiCe video podcast w/ Amy Schulman of @PolarisVC and hear about her early career as a lawyer led to her General Counsel and Business Unit Executive at Pfizer before becoming a VC at Polaris, where she has led life science investments for over a decade as Managing Partner. The full video is here on @BiotechTV (and also on Spotify and Apple Podcasts): biotechtv.com/post/bioventur…
BiotechTV@BiotechTV

𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: @PolarisVC's Amy Schulman describes how her career in law led to running businesses for Pfizer and ultimately joining the VC world. She shares leanings from the last 10 years of biotech investing. Full video: biotechtv.com/post/bioventur…

English
1
1
11
2.3K
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Our next guest (Ep.31) on @BioVentureVoiCe video podcast will be Amy Schulman of @PolarisVC (polarispartners.com), where she has been leading biotech investments for over a decade. She shares her prior experience as GC and business leader for @pfizer along with her law firm roots which shaped the way she approaches problem solving for biotechs today. Tune in early next week to listen to this episode of BioVenture VoiCes on @BiotechTV!
Chris Garabedian tweet media
English
0
1
8
1.1K
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Listen to Episode 30 of @BioVentureVoiCe video podcast w/ Stephen Knight of @FPrimeCapital and hear about the early days of shaping the VC strategy of its single LP, Fidelity. Steve has overseen investments in life sciences for F-Prime for over 20 years, including some of the most notable emerging technologies in biotech. The full video is here on @BiotechTV (and also on Spotify and Apple Podcasts): biotechtv.com/post/bioventur…
BiotechTV@BiotechTV

𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: @FPrimeCapital Senior Managing Partner Stephen Knight on doing venture capital in life sciences in its early days, and F-Prime today. Full video: biotechtv.com/bioventure-voi…

English
0
2
10
2.1K
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Our next guest (Ep.30) on @BioVentureVoiCe video podcast will be Stephen Knight of @FPrimeCapital (fprimecapital.com), where he has been leading biotech investments for over 20 years. Hear how his early experience as an MD/MBA from Yale in consulting and building startups led to his role in venture capital at F-Prime and managing investments for his single LP, Fidelity Investments. Tune in early next week to listen to this episode of BioVenture VoiCes on @BiotechTV!
Chris Garabedian tweet media
English
0
1
1
461
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Listen to Episode 29 of @BioVentureVoiCe video podcast w/ @DavidBerry26 of @averincapital and hear him describe his philosophy of creating innovative startups, which he did for @FlagshipPioneer for over 15 years before starting his own VC with his brother to invest at the nexus of emerging tech/AI and life sciences. The full video is here on @BiotechTV (and also on Spotify and Apple Podcasts): biotechtv.com/post/bioventur…
BiotechTV@BiotechTV

𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: @averincapital Managing Partner @DavidBerry26 on investing at the intersection of healthcare and technology. Full video: biotechtv.com/post/bioventur…

English
0
2
7
1.6K
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Our next guest (Ep.29) on @BioVentureVoiCe video podcast will be @DavidBerry26 of @averincapital (averincapital.com), who shares his early experiences and 15 years at @FlagshipPioneer with company creation before starting his own VC firm with his brother to invest at the nexus of technology/AI and life sciences. He shares his perspective on being the first to pursue an idea that only looks obvious in hindsight. Tune in early next week to listen to this episode of BioVenture VoiCes on @BiotechTV!
Chris Garabedian tweet media
English
0
1
4
831
BioVentureVoiCes retweetledi
Chris Garabedian
Chris Garabedian@cngarabedian·
Listen to Episode 28 of @BioVentureVoiCe video podcast w/ Clay Thorp of Hatteras Venture Partners (hatterasvp.com) and hear him describe his investing history over 25 years and 100 companies born out of his connections within the North Carolina life sciences ecosystem. Hatteras closed their 7th Venture Fund in 2025. The full video is here on @BiotechTV (and also on Spotify and Apple Podcasts): biotechtv.com/post/bioventur…
BiotechTV@BiotechTV

𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: Hatteras Venture Partners' Clay Thorp on investing in the strengths of the North Carolina life sciences ecosystem and beyond. Full video: biotechtv.com/post/bioventur…

English
1
1
9
1.1K

Keşfet

@cngarabedian @BiotechTV @generalatlantic @pappas_capital @rtnarch @PolarisVC @pfizer @FPrimeCapital